- No articles yet.
NHS Approves First Drug to Delay Type 1 Diabetes
The National Institute for Health and Care Excellence (NICE) gave the green light for the drug, which works by modulating the immune system to prevent the destruction of insulin-producing cells.
It can give patients years before they need to start insulin therapy.
Diabetes UK hailed the decision as a landmark moment.
The drug will be available through the NHS, offering hope to thousands at risk of the condition.
National Health Service
Publicly funded healthcare system of England
Publicly funded healthcare system of England
Teplizumab
Chemical compound
Chemical compound
Type-1 diabetes
Autoimmune disease, a form of diabetes mellitus that occurs when insulin-producing cells are destroyed by the immune system
Autoimmune disease, a form of diabetes mellitus that occurs when insulin-producing cells are destroyed by the immune system
National Institute for Health and Care Excellence
Non-departmental public body of the Department of Health in the United Kingdom
Non-departmental public body of the Department of Health in the United Kingdom